David
Gómez Fernández
Investigador en el periodo 2021-2023
Publicaciones en las que colabora con David Gómez Fernández (10)
2024
-
A Multi-Target Pharmacological Correction of a Lipoyltransferase LIPT1 Gene Mutation in Patient-Derived Cellular Models
Antioxidants, Vol. 13, Núm. 8
-
Polydatin and Nicotinamide Rescue the Cellular Phenotype of Mitochondrial Diseases by Mitochondrial Unfolded Protein Response (mtUPR) Activation
Biomolecules, Vol. 14, Núm. 5
2023
-
Actin Polymerization Defects Induce Mitochondrial Dysfunction in Cellular Models of Nemaline Myopathies
Antioxidants, Vol. 12, Núm. 12
-
Alpha-lipoic acid supplementation corrects pathological alterations in cellular models of pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
Orphanet journal of rare diseases, Vol. 18, Núm. 1, pp. 80
-
Antioxidants Prevent Iron Accumulation and Lipid Peroxidation, but Do Not Correct Autophagy Dysfunction or Mitochondrial Bioenergetics in Cellular Models of BPAN
International Journal of Molecular Sciences, Vol. 24, Núm. 19
-
Mitochondrial Quality Control via Mitochondrial Unfolded Protein Response (mtUPR) in Ageing and Neurodegenerative Diseases
Biomolecules, Vol. 13, Núm. 12
-
Neurodegeneration, Mitochondria, and Antibiotics
Metabolites, Vol. 13, Núm. 3
-
Patient-Derived Cellular Models for Polytarget Precision Medicine in Pantothenate Kinase-Associated Neurodegeneration
Pharmaceuticals, Vol. 16, Núm. 10
-
mtUPR Modulation as a Therapeutic Target for Primary and Secondary Mitochondrial Diseases
International Journal of Molecular Sciences, Vol. 24, Núm. 2
2022
-
Pterostilbene in Combination With Mitochondrial Cofactors Improve Mitochondrial Function in Cellular Models of Mitochondrial Diseases
Frontiers in Pharmacology, Vol. 13